Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Angina (Carvedilol - Angina)

Records returned : 22 (on 14 Mar 2026 at 09:30:50). Return to search results for ' Angina '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important
Prescribe by BRAND
Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release capsules
Restrictions / Comments:

Important
Prescribe by BRAND
Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Sublingual spray
  • Sublingual tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Patches
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release tablets
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred
Twice daily (assymetric) dosing is recommended
 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Modified release capsules
  • Modified release tablets
Restrictions / Comments:

Important
Restricted to when isosorbide mononitrate standard release is not suitable. Primary Care prescribers should follow local advice on the most cost-effective brands. OptimiseRx will be used to identify current recommendations.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important

Prescribe by BRAND.

 

Nifedipine once-daily tablets : there are limited options available on the market following the discontinuation of Adalat LA, Adipine XL and Fortipine LA. Prescribers should consider a twice-daily nifedipine tablet or a once-daily capsule. Additional information is available here: Discontinuation of Nifedipine (Adipine XL) 30mg and 60mg modified-release tablets – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release capsules
Restrictions / Comments:

Important

Prescribe by BRAND.

 

Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release capsules
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Modified release capsules
  • Modified release tablets
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Oral solution
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important

This is not a preferred treatment option but existing, stable patients may remain on treatment.

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Restricted to cardiology. Specialist initiation and at least one month supply before transfer to primary care
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Modified release tablets
Restrictions / Comments:

Important

Restricted to cardiology

On recommendation from the specilist team

 

 
Links :
SPC